JP2018505861A5 - - Google Patents

Download PDF

Info

Publication number
JP2018505861A5
JP2018505861A5 JP2017533018A JP2017533018A JP2018505861A5 JP 2018505861 A5 JP2018505861 A5 JP 2018505861A5 JP 2017533018 A JP2017533018 A JP 2017533018A JP 2017533018 A JP2017533018 A JP 2017533018A JP 2018505861 A5 JP2018505861 A5 JP 2018505861A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
terminal
terminal peptide
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018505861A (ja
JP6912379B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/080924 external-priority patent/WO2016102536A1/en
Publication of JP2018505861A publication Critical patent/JP2018505861A/ja
Publication of JP2018505861A5 publication Critical patent/JP2018505861A5/ja
Application granted granted Critical
Publication of JP6912379B2 publication Critical patent/JP6912379B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533018A 2014-12-23 2015-12-22 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物 Active JP6912379B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14307154.6 2014-12-23
EP14307154 2014-12-23
PCT/EP2015/080924 WO2016102536A1 (en) 2014-12-23 2015-12-22 Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020033407A Division JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Publications (3)

Publication Number Publication Date
JP2018505861A JP2018505861A (ja) 2018-03-01
JP2018505861A5 true JP2018505861A5 (enExample) 2018-10-25
JP6912379B2 JP6912379B2 (ja) 2021-08-04

Family

ID=52432622

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017533018A Active JP6912379B2 (ja) 2014-12-23 2015-12-22 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物
JP2020033407A Pending JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020033407A Pending JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Country Status (5)

Country Link
US (1) US10736937B2 (enExample)
EP (1) EP3236988B8 (enExample)
JP (2) JP6912379B2 (enExample)
ES (1) ES2809598T3 (enExample)
WO (1) WO2016102536A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52545B1 (fr) * 2018-04-16 2024-08-30 F. Hoffmann-La Roche Ag Anticorps pour radionucléides chélatés
FR3114970B1 (fr) 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
KR20240027752A (ko) 2021-06-30 2024-03-04 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 플라겔린의 폐 전달을 위한 에어로졸 조성물
WO2025172452A1 (en) 2024-02-14 2025-08-21 Institut National de la Santé et de la Recherche Médicale Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2300609T3 (da) * 2008-06-25 2014-02-10 Inst Nat Sante Rech Med Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
EP2585094B1 (en) * 2010-06-25 2018-08-01 INSERM - Institut National de la Santé et de la Recherche Médicale Flagellin polypeptide as tlr5 agonist for use in the treatment of respiratory tract infections
EP2903622A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
US20150246095A1 (en) 2012-10-03 2015-09-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
JP6274904B2 (ja) * 2014-02-25 2018-02-07 キヤノン株式会社 固体撮像装置及び撮像システム

Similar Documents

Publication Publication Date Title
ES2271468T3 (es) Nuevas indicaciones de la lecitina de union a manano (mbl) en el tratamiento de individuos inmunocomprometidos.
JP2018511327A5 (enExample)
JP2018505861A5 (enExample)
JP2006507270A5 (enExample)
JP2015522576A5 (enExample)
JP2015517489A5 (enExample)
JP2013534532A5 (enExample)
IL262805B2 (en) Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
JP2019533722A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
JP2016529229A5 (enExample)
JP2017526627A5 (enExample)
JP2017532343A5 (enExample)
JP2018528763A5 (enExample)
HRP20161458T1 (hr) Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
BR112015028429A2 (pt) Composição imunogênica baseada em um imunógeno do peptídeo gastrina-17, uma vacina compreendendo a composição imunogênica, um kit para preparação da composição imunogênica, e sua utilização médica no tratamento de doenças gastrina dependentes
JP2017505772A5 (enExample)
JP2017536124A5 (enExample)
JP2016515123A5 (enExample)
RU2016135003A (ru) Новые виды лечения
JP2025041746A5 (enExample)
JP2017519763A5 (enExample)
JP2015515280A5 (enExample)